Jan 21 Johnson & Johnson reported
quarterly results that came in above Wall Street estimates on
sharply higher sales of its prescription drugs and improving
sales of its medical devices.
The diversified healthcare company said on Tuesday it earned
$3.52 billion, or $1.23 per share, in the fourth quarter. That
compared with $2.57 billion, or 91 cents per share, in the
year-earlier period, when J&J took a charge of $800 million
related mostly to recalls of defective "metal-on-metal" hip
Excluding special items, J&J earned $1.24 per share.
Analysts, on average, expected $1.20 per share, according to
Thomson Reuters I/B/E/S.